Robert K. Zeldin - 25 Jun 2026 Form 4 Insider Report for MeiraGTx Holdings plc (MGTX)

Reporting relationship: CHIEF MEDICAL OFFICER
Issuer ticker: MGTX
Reported as of: 25 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Jun 2026, 21:19:15 UTC
Prior SEC filing: 23 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Robert J. Wollin, Attorney-in-Fact for Robert K. Zeldin

Key filing fact

Robert K. Zeldin filed Form 4 for MeiraGTx Holdings plc (MGTX) on 29 Jun 2026.

Key facts

This page summarizes Robert K. Zeldin's Form 4 filing for MeiraGTx Holdings plc (MGTX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 29 Jun 2026, 21:19.

Change

Previous filing in this sequence was filed on 23 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001745347 Primary reporting owner

Zeldin Robert K

Relationship: CHIEF MEDICAL OFFICER
Address: 655 THIRD AVENUE, SUITE 1115, NEW YORK
Signature: /s/ Robert J. Wollin, Attorney-in-Fact for Robert K. Zeldin
Signature date: 29 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MGTX transaction Derivative

Restricted Share Units

Award

Transaction value
Shares: +100,000
Change %
Price: $0.000000^*
Shares after: 100,000
Date: 25 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 100,000
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted share unit converts into one ordinary share upon vesting.

Footnote F2

Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date.